Lv22
108 积分 2023-05-22 加入
不同BCR-ABL融合基因转录本慢性髓细胞白血病患者的临床特征及预后研究进展
10天前
已关闭
Consensus on the management of cutaneous adverse reactions to anti-tumor drugs
14天前
已完结
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
23天前
已完结
An evaluation of ravulizumab for the treatment of neuromyelitis optica spectrum disorder
23天前
已完结
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel
23天前
已完结
Efficacy and safety of EGFR inhibitors and radiotherapy in locally advanced non-small-cell lung cancer: a meta-analysis
28天前
已完结
前列腺癌根治术后辅助内分泌治疗热点问题和专家共识
28天前
已完结
Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study
1个月前
已完结
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase
1个月前
已完结
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study
1个月前
已完结
皖公网安备34019202002308
